MACROD2 Gene May Explain Why Some Breast Cancers are Resistant to Tamoxifen

Share this content:
MACROD2 gene may explain why some breast cancers are resistant to tamoxifen
MACROD2 gene may explain why some breast cancers are resistant to tamoxifen
After mining the genetic records of thousands of breast cancer patients, researchers from the Johns Hopkins Kimmel Cancer Center have identified a gene whose presence may explain why some breast cancers are resistant to tamoxifen, a widely used hormone treatment generally used after surgery, radiation and other chemotherapy.
READ FULL ARTICLE From News Medical
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters